Please login to the form below

Not currently logged in
Email:
Password:

research costs

This page shows the latest research costs news and features for those working in and with pharma, biotech and healthcare.

BMS and Eisai to collaborate in deal worth up to $3.1bn

BMS and Eisai to collaborate in deal worth up to $3.1bn

Both companies will share the profits, research and development and commercialisation costs in the collaboration territories. ... The Eisai collaboration is the latest in a string of strategic deals agreed by BMS in the oncology research area.

Latest news

More from news
Approximately 0 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • The 2019 CPhI Pharma Index Report The 2019 CPhI Pharma Index Report

    Competitiveness. The industry experts assessed each market’s competitiveness on a variety of factors including the country’s labour costs, quality of skilled labour, research potential and tax environment.

  • The Golden Goose The Golden Goose

    to make enough money in aggregate [emphasis added] to cover initial research costs.but [this] leads manufacturers to price discriminate across markets and may lead to a sense that some markets ... Haislmaier, senior research fellow at the Heritage

  • Cost containment and the German market Cost containment and the German market

    The country provides a growing healthcare market for manufacturers, with a good infrastructure, qualified employees and a number of research institutions enabling a productive knowledge exchange. ... Innovative medicine requires high research and

  • Applying real-world evidence to orphan drugs Applying real-world evidence to orphan drugs

    However, for many rare disease therapies, the research and development (R&D) costs far outweigh the expected revenue once the product is launched. ... In Europe, the EU Committee of Experts on Rare Diseases (EUCERD) and the European Platform for Rare

  • The Maverick: giving medicines away free The Maverick: giving medicines away free

    Why patent it, when it won't work on anyone else?”. He says this model also cuts down on research and development costs, which he claims could be reduced to just ... This would also drastically reduce manufacturing costs. He also wants other

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Is agile working benefiting the employee or the organisation?

    Beyond reduced office costs, research tells us that agile working improves morale, increases staff retention and importantly widens and unlocks a bigger talent pool. ... In this blog Angela draws on her experience and reflects on how the development of

  • AskMED.co.uk

    AskMED brings medical professionals together online to provide rapid analysis and feedback for industry questions at a fraction of traditional research costs.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....